Cargando…

House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma

Background: Allergen-specific immunotherapy is currently the only disease-modifying treatment for allergic asthma, and it has been shown to improve control of asthma while reducing both drug use and asthma exacerbations. However, its effects on lung function—especially its long-term effects—remain c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nogami, Kazutaka, Nagao, Mizuho, Takase, Takafumi, Yasuda, Yasuaki, Yamada, Shingo, Matsunaga, Mayumi, Hoshi, Miyuki, Hamada, Kana, Kuwabara, Yu, Tsugawa, Takeshi, Fujisawa, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028398/ https://www.ncbi.nlm.nih.gov/pubmed/35455531 http://dx.doi.org/10.3390/children9040487

Ejemplares similares

Three cases of severe adolescent asthma treated with mepolizumab: lung function trajectories
por: Hoshi, Miyuki, et al.
Publicado: (2020)

Intake of allergenic foods at 1.5 years and 3 years of age in a general child population in Japan: a cross-sectional study
por: Takase, Takafumi, et al.
Publicado: (2023)

Asthma diagnosis and treatment – 1007. Clinical application of forced oscillation technique for children with asthma
por: Kainuma, Keigo, et al.
Publicado: (2013)

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021)

Systemic Reactions to Dust Mite Subcutaneous Immunotherapy: A 3-Year Follow-up Study
por: Dong, Xiang, et al.
Publicado: (2016)

Season of birth is associated with increased risk of atopic dermatitis in Japanese infants: a retrospective cohort study
por: Kuwabara, Yu, et al.
Publicado: (2020)

Food allergy and anaphylaxis - 2041. Rush oral immunotherapy for severe food allergy: one year follow up
por: Sugimoto, Mayumi, et al.
Publicado: (2013)

Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
por: Kim, Myoung-Eun, et al.
Publicado: (2011)

Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
por: Rattanamanee, Tipyapa, et al.
Publicado: (2022)

Sensitization to secretoglobin and lipocalins in a group of young children with risk of developing respiratory allergy
por: Nagao, Mizuho, et al.
Publicado: (2017)

Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017)

House dust mites atopy patch test - an important screening tool for detection of house dust mites allergy?
por: Jasiewicz-Honkisz, Barbara, et al.
Publicado: (2015)

Sensitization by subcutaneous route is superior to intraperitoneal route in induction of asthma by house dust mite in a murine mode
por: Aun, Marcelo Vivolo, et al.
Publicado: (2015)

A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
por: Lee, Ji-Ho, et al.
Publicado: (2018)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Retrospective evaluation of adverse reactions after subcutaneous allergen-specific immunotherapy in children with house dust mite allergy
por: Altas, Ugur, et al.
Publicado: (2023)

Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis
por: Caruso, Cristiano, et al.
Publicado: (2023)

Food allergy and anaphylaxis – 2045. Highly elevated IgE antibodies to vaccine components in influenza vaccine-associated anaphylaxis in Japan
por: Nagao, Mizuho, et al.
Publicado: (2013)

226 Analysis of an After-Care Questionnaire in Allergic People to Dust Mites Using Anti-Dust Mites Bed Covers
por: Boukhettala, Nabile, et al.
Publicado: (2012)

Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
por: Rieker-Schwienbacher, Juliane, et al.
Publicado: (2013)

Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
por: HUI, YU, et al.
Publicado: (2014)

Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
por: Zheng, Chen, et al.
Publicado: (2023)

Standardization of House Dust Mite Extracts in Korea
por: Jeong, Kyoung Yong, et al.
Publicado: (2012)

Do Other Components of Bedding Dust Affect Sensitisation to House Dust Mites?
por: Smith, Claire, et al.
Publicado: (2012)

Group 2 Innate Lymphoid Cells and the House Dust Mite-Induced Asthma Mouse Model
por: Yasuda, Yuichiro, et al.
Publicado: (2020)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
por: Proctor, Thomas, et al.
Publicado: (2020)

Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust
por: Lim, Fang Lee, et al.
Publicado: (2015)

Describing fluctuating indoor aerosol dust measurements with application to house dust mite allergens
por: van Boven, F. E., et al.
Publicado: (2020)

House dust mite control measures in the treatment of asthma
por: Vallance, Gillian, et al.
Publicado: (2006)

Variability of house dust mite allergen exposure in dwellings.
por: Hirsch, T, et al.
Publicado: (1998)

Innate Immune Responses in House Dust Mite Allergy
por: Jacquet, Alain
Publicado: (2013)

Shellfish and House Dust Mite Allergies: Is the Link Tropomyosin?
por: Wong, Lydia, et al.
Publicado: (2016)

Allergens with Protease Activity from House Dust Mites
por: Reithofer, Manuel, et al.
Publicado: (2017)

House Dust Mite Allergy Under Changing Environments
por: Acevedo, Nathalie, et al.
Publicado: (2019)

Shrimp sensitization in house dust mite allergic patients
por: Ukleja-Sokołowska, Natalia, et al.
Publicado: (2020)

New approaches to immunotherapy in house dust mite allergy
por: Kim, In Sik
Publicado: (2022)

Investigating the microbiome of house dust mites in South Korea
por: Yi, Myung-hee, et al.
Publicado: (2023)

Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy
por: Kim, Nacksung, et al.
Publicado: (2006)

iTRAQ-based proteomic analysis reveals potential regulatory networks in dust mite-related asthma treated with subcutaneous allergen immunotherapy
por: Bai, Jun, et al.
Publicado: (2020)

Tropomyosin in mugwort cross-reacts to house dust mite, eliciting non-Th2 response in allergic rhinitis patients sensitized to house dust mite
por: Duan, Su, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ft73cosit7p9b8jsfnekmfkn8t